Open AccessChemoprevention and Treatment of Pancreatic Cancer: Update and Review of the Literature
Author(s) -
Julia Benzel,
Volker Fendrich
Publication year - 2018
Publication title -
digestion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.882
H-Index - 75
eISSN - 1421-9867
pISSN - 0012-2823
DOI - 10.1159/000485741
Subject(s) - medicine , pancreatic intraepithelial neoplasia , pancreatic cancer , aspirin , disease , cancer , metformin , curcumin , oncology , bioinformatics , pharmacology , pancreatic ductal adenocarcinoma , insulin , biology
Pancreatic ductal adenocarcinoma is one of the most lethal types of cancer with a 5-year survival rate of around 7%. Due to the relatively poor prognosis, the potential need of an effective chemoprevention is highly needed.